Biotech

The Readout Meghana Keshavan

STAT Plus: The biotech news you need to read today

Politics John Wilkerson

STAT Plus: It might be now or never for the BIOSECURE Act

Health Lizzy Lawrence

STAT Plus: Trump taps biotech investor Jim O’Neill for HHS deputy secretary

Exclusive Allison DeAngelis

STAT Plus: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

D.C. Diagnosis Sarah Owermohle

STAT Plus: Unpacking Trump’s latest picks for top health roles

The Readout Adam Feuerstein

STAT Plus: Roche’s TIGIT troubles continue, a novel Alzheimer’s target misses the mark, and other biotech news

Biotech Jason Mast

STAT Plus: Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases

Biotech Andrew Joseph

STAT Plus: Amgen drug leads to substantial weight loss in study, but questions remain about competitiveness

Biotech Jason Mast

STAT Plus: Alector Therapeutics’ novel Alzheimer’s strategy fails in Phase 2 trial 

Adam's Take Adam Feuerstein

STAT Plus: Cassava Sciences and its Alzheimer’s drug are done. The damage lingers

The Readout Meghana Keshavan

STAT Plus: What to make of Trump’s health care nominees

Biotech Allison DeAngelis, Adam Feuerstein, Matthew Herper, Lizzy Lawrence, Nicholas St. Fleur, and Jonathan Wosen

STAT Plus: ‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner

Politics Lizzy Lawrence

STAT Plus: Trump picks Johns Hopkins surgeon Makary to run FDA

Biotech Elaine Chen

STAT Plus: BridgeBio wins FDA approval for heart disease drug

The Readout Meghana Keshavan

STAT Plus: More beef in the gene editing space

Biotech Jason Mast

STAT Plus: Novartis buys gene therapy startup Kate Therapeutics, joining pursuit of muscular dystrophy treatment

The Readout Meghana Keshavan

STAT Plus: Versant enters obesity with new startup

Biotech Adam Feuerstein

STAT Plus: Kura licenses leukemia drug to Japanese drugmaker

The Pharmalot View Ed Silverman

STAT Plus: RFK Jr. wants to blow up the ‘corrupt’ FDA, but he could Make America Sick Again

The Readout Meghana Keshavan

STAT Plus: Investors tell Silence Therapeutics to shush 

Health tech Brittany Trang

STAT Plus: AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO

Pharma Andrew Joseph

STAT Plus: With RFK Jr. looming as health secretary, pharma execs try to project stability

The Readout Meghana Keshavan

STAT Plus: A win for Apellis, a setback for Astellas

Biotech Matthew Herper and Allison DeAngelis

STAT Plus: Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast

The Readout Meghana Keshavan

STAT Plus: Novartis ramps up in radiopharma, and Eli Lilly adds Zepbound details

Biotech Adam Feuerstein

STAT Plus: Syndax wins U.S. approval for leukemia treatment

Biotech Adam Feuerstein

STAT Plus: Regenxbio says gene therapy strengthened boys with Duchenne muscular dystrophy

Biotech Jason Mast

STAT Plus: Intellia says CRISPR therapy shows superior gain for cardiomyopathy patients

Politics Rachel Cohrs Zhang

STAT Plus: How RFK Jr. could strip legal protections from vaccine makers as HHS Secretary